As of 2026-03-13, the Relative Valuation of BioLife Solutions Inc (BLFS) is (1.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.15 USD, the upside of BioLife Solutions Inc based on Relative Valuation is -109.1%.
The range of the Relative Valuation is (1.60) - (1.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 27.8x | 22.8x |
| Forward P/E multiples | 18.1x - 23.6x | 19.6x |
| Fair Price | (1.60) - (1.84) | (1.65) |
| Upside | -108.8% - -110.1% | -109.1% |
| Date | P/E |
| 2026-03-12 | -233.75 |
| 2026-03-11 | -244.83 |
| 2026-03-10 | -240.45 |
| 2026-03-09 | -256.29 |
| 2026-03-06 | -255.78 |
| 2026-03-05 | -259.12 |
| 2026-03-04 | -266.21 |
| 2026-03-03 | -259.77 |
| 2026-03-02 | -290.03 |
| 2026-02-27 | -311.67 |
| 2026-02-26 | -289.52 |
| 2026-02-25 | -289.39 |
| 2026-02-24 | -291.71 |
| 2026-02-23 | -294.67 |
| 2026-02-20 | -297.38 |
| 2026-02-19 | -299.18 |
| 2026-02-18 | -294.16 |
| 2026-02-17 | -287.97 |
| 2026-02-13 | -286.30 |
| 2026-02-12 | -277.93 |
| 2026-02-11 | -286.56 |
| 2026-02-10 | -291.71 |
| 2026-02-09 | -291.45 |
| 2026-02-06 | -288.87 |
| 2026-02-05 | -283.59 |
| 2026-02-04 | -291.97 |
| 2026-02-03 | -294.16 |
| 2026-02-02 | -287.59 |
| 2026-01-30 | -280.76 |
| 2026-01-29 | -290.81 |
| 2026-01-28 | -295.44 |
| 2026-01-27 | -321.72 |
| 2026-01-26 | -321.20 |
| 2026-01-23 | -320.30 |
| 2026-01-22 | -334.60 |
| 2026-01-21 | -329.06 |
| 2026-01-20 | -318.88 |
| 2026-01-16 | -314.50 |
| 2026-01-15 | -315.15 |
| 2026-01-14 | -312.83 |
| 2026-01-13 | -307.81 |
| 2026-01-12 | -309.61 |
| 2026-01-09 | -320.17 |
| 2026-01-08 | -321.33 |
| 2026-01-07 | -327.25 |
| 2026-01-06 | -339.36 |
| 2026-01-05 | -325.97 |
| 2026-01-02 | -307.68 |
| 2025-12-31 | -311.41 |
| 2025-12-30 | -317.60 |